They consist of compounded tirzepatide (oral or injectable), compounded semaglutide (oral or injectable), compounded GLP-1 microdose (for weight maintenance after you reach your weight goal), and brand-name medications
99% Analytical Purity Third-Party Analytical Testing HPLC Verification Mass Spectrometry Identity Confirmation Net Peptide Content Verification Batch-Specific Certificate of Analysis GLOW Blend combines three of the most-studied regenerative research peptides BPC-157 , TB-500 (Thymosin Beta-4 fragment) , and GHK-Cu (copper tripeptide-1) in a single lyophilized vial for laboratory research into connective tissue, collagen-signaling, and tissue-regeneration pathways
Medical Writing, Editorial, and Other Assistance The authors would like to thank Adele Musicant, PhD, of Precision AQ (Bethesda, Maryland) who provided writing and editing assistance according to Good Publication Practice guidelines (GPP 2022)
According to UCLA Health, semaglutide was the first drug approved since 2014 specifically for chronic weight management in the majority of American adults who are classified as overweight or obese, yet insurance treatment of that weight-loss indication still lags well behind how insurers treat the diabetes indication for the same molecule
However, these drugs shouldnt be seen as miracle cures
Tirzepatide holds FDA approval for chronic weight management
